3,4-methylenedioxyamphetamine has been researched along with Central Nervous System Diseases in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HY | 1 |
| Chien, WC | 1 |
| Huang, MN | 1 |
| Fang, CC | 1 |
| Weng, TI | 1 |
| Woolverton, WL | 1 |
1 review available for 3,4-methylenedioxyamphetamine and Central Nervous System Diseases
| Article | Year |
|---|---|
A review of the effects of repeated administration of selected phenylethylamines.
Topics: 3,4-Methylenedioxyamphetamine; Alkaloids; Amphetamines; Animals; Central Nervous System; Central Ner | 1986 |
1 other study available for 3,4-methylenedioxyamphetamine and Central Nervous System Diseases
| Article | Year |
|---|---|
Analytically confirmed eutylone (bk-EBDB) exposure in emergency department patients.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Alkaloids; Central Nervous System Diseases; Centra | 2021 |